Toggle Nav
Close
  • Menu
  • Setting

Anti-Amyloid Beta Antibody (Solanezumab)

Catalog No.
F1534
Anti-Amyloid Beta Antibody (Solanezumab)
Grouped product items
SizePriceStock Qty
100ug
$90.00
Ship with 3-5 days
1mg
$270.00
Ship with 3-5 days
5mg
$702.00
Ship with 3-5 days
50mg
$2,359.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Solanezumab is a humanized monoclonal IgG1 antibody targeting the middle domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for Alzheimer's disease research.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

144.34 kDa

Shipping

Dry ice

Cas No.

955085-14-0

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

LY2062430, m266, 10D5

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P05067

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

The purity of Anti-Amyloid Beta Antibody (Solanezumab) is 96.84%, determined by SEC-HPLC.

Target

Amyloid Beta

Note

Please avoid freeze-thaw cycles.